-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on AVITA Medical, Raises Price Target to $21

Benzinga·11/06/2026 10:39:54
Listen to the news
BTIG analyst Ryan Zimmerman maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $15 to $21.